Pfizer’s Ibrance kisses early breast cancer hopes goodbye with second study failure chelfand Fri, 10/09/2020 – 11:42

Eli Lilly’s Olumiant pares COVID-19 patients’ recovery time down to 7 days as an add-on to remdesivir kblankenship […]

Gilead Sciences’ remdesivir cuts COVID-19 death risk in patients on low-flow oxygen esagonowsky Fri, 10/09/2020 – 09:30

U.K. manufacturer Abzena pumps $60M into new biologics facility in San Diego kblankenship Fri, 10/09/2020 – 08:46

Multidisciplinary tumor boards are vital to cancer treatment plans, bringing together clinicians from different specialties to guide patient […]

There is great potential in gene therapy for treating certain types of cancer and genetic defects, immunological diseases, […]

Brain science is still in a discovery phase because of our limited knowledge of basic nervous system structure […]

Cerebrovascular diseases and dementia are two leading contributors to impairment of brain health and neurological disability in older […]

Monogenic diseases result from modifications to a single gene. Over 10 000 monogenic diseases have been identified, around […]

Fadraciclib has passed safety trials and shown early efficacy